|Podcasts|March 21, 2023
Health Equity In Clinical Trials
Author(s)Lisa Henderson
Rose Blackburne, MD, MBA, Vice President, Global Head, General Medicine, PPD Clinical Research, Thermo Fisher and Margarita Nunez, MD, Principal Investigator, Synexus NY / Accelerated Enrollment Solutions New York discuss their panel at the recent Health Equity in Clinical Trials Congress in Boston last month; share insights into how diversity can be improved at the site and CRO; and the hope that clinical trial awareness and diversity can be discussed with all levels of stakeholders in healthcare to improve drug development worldwide.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Execution Failures and Upstream Origins, European Data Governance Reshaping CROs, and Phase-Dependent Trial Competition
2
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
3
ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism
4
The AI Churn Trap in Life Sciences and How to Break It
5